Latest Boardroom Shifts News

Northern Star Resources acknowledges activist investor Elliott's stake and proposals, confirms ongoing CEO recruitment, and highlights progress on key projects while rejecting a sale process.

ImpediMed has successfully closed an oversubscribed Share Purchase Plan, raising $2.1 million following a $13.2 million institutional placement. The strong shareholder response underscores confidence ahead of a key shareholder vote.

Helia Group appoints Mark Senkevics as CEO from December 2026 and Craig Ward as CFO from July 2026, outlining detailed remuneration and transition plans amid ongoing leadership changes.

ArborGen Holdings announces CEO Justin Birch's resignation after three years, appointing Patrick Cumbie as interim CEO while searching for a permanent replacement.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.

Conrad Asia Energy appoints Peter Botten as Executive Chairman and initiates CEO search amid transition to gas producer with first gas targeted for late 2027.

Elanor Investors Group appoints David McNamara as CEO, signaling a leadership shift following a balance sheet recapitalisation and strategic reset. The Board also sees key transitions with Tony Fehon moving to a non-executive role and Su Kiat Lim stepping down.

XPON Technologies is shedding Alpha Digital after just over a year, in a move that clears the way for a tighter AI-centric growth strategy. The deal involves significant debt forgiveness, reflecting a clean break from a services-led business that once contributed over a third of group revenue.

Promisia Healthcare reported a 58% jump in underlying EBITDAF to $6.6 million for FY26, driven by improved occupancy and operational upgrades. The company introduced a dividend policy tied to operating free cash flow, signalling confidence in sustained cash generation.

Group 6 Metals disclosed breaches of ASX Listing Rule 10.1 due to related party transactions made without required shareholder approval during a period of negative equity. The company will seek retrospective approval at a July meeting and has since returned to positive equity.

ImpediMed has revamped its leadership with two new commercial roles and reported encouraging sales momentum for its SOZO device. The company is advancing clinical trials and expanding its presence in cancer survivorship, weight management, and heart health sectors.

Resouro Strategic Metals has locked in a binding agreement with Future Mining and Buri Gold to fund and operate mining and processing at its Novo Mundo gold project in Brazil, aiming to generate cash flow without diverting capital from its flagship Tiros project.